Tirzepatide (GLP-2) – 100mg

Research Applications:

Dual Incretin Receptor Signaling

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. In research settings, it is used to study incretin receptor crosstalk, metabolic signaling, and downstream glucose-response pathways [1].
This dual agonist profile supports comparative studies against GLP-1-only or multi-agonist metabolic peptides.

Metabolic Pathway Models

Laboratory models can evaluate effects on receptor activation, insulin-response signaling, appetite-pathway markers, and energy-balance endpoints without making treatment claims.

Comparative GLP Research Context

Tirzepatide pairs naturally with retatrutide-oriented research content, but remains distinct as a GIP/GLP-1 dual agonist rather than a triple agonist.

Referenced Citations:

1. Tirzepatide compound reference
   Source: PubChem compound reference for tirzepatide and dual receptor classification.